Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe Asthma

30 Mar 2021

Abstract excerpt

There is currently enough evidence to think that miRNAs play a role in several key points in asthma, including diagnosis, severity of the disease, and response to treatment. Cells release different types of lipid double-membrane vesicles into the extracellular microenvironment, including exosomes, which function as very important elements in intercellular communication. They are capable of distributing genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asthma and respiratory diseases
Share to Extracellular vesicles in disease
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33808110
DOI: 10.3390/ijms22073558

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe AsthmaPMID 33808110Read ↗

Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patientsSemantic proximity Read ↗

RNA‐seq–based profiling of extracellular vesicles in plasma reveals a potential role of miR‐122‐5p in asthmaSemantic proximity Read ↗

Exosomes in Severe Asthma: Update in Their Roles and Potential in TherapySemantic proximity Read ↗

Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab.Semantic proximity Read ↗

Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factorsSemantic proximity Read ↗

Asthma diagnosis using integrated analysis of eosinophil microRNAsSemantic proximity Read ↗

Serum microRNAs Catalog Asthma Patients by Phenotype.Semantic proximity Read ↗

Role of microRNAs in inflammatory upper airway diseasesSemantic proximity Read ↗

microRNAs in asthma: potential therapeutic targets.Semantic proximity Read ↗

Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral GlucocorticoidsSemantic proximity Read ↗

Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity.Semantic proximity Read ↗

Circulating miRNAs act as potential biomarkers for asthmaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.